Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease

Min Shi, Cyrus P. Zabetian, Aneeka M. Hancock, Carmen Ginghina, Zhen Hong, Dora Yearout, Kathryn (Kathy) Chung, Joseph Quinn, Elaine R. Peskind, Douglas Galasko, Joseph Jankovic, James B. Leverenz, Jing Zhang

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

DJ-1 and α-synuclein are leading biomarkers for Parkinson's disease diagnosis and/or monitoring disease progression. A few recent investigations have determined DJ-1 and α-synuclein levels in plasma or serum, a more convenient sample source than cerebrospinal fluid; but the results were variable or even contradictory. Besides limitations in detection technology and limited number of cases in some studies, inadequate control of several important confounders likely has contributed to these inconsistent results. In this study, the relative contribution of each blood component to blood DJ-1 and α-synuclein was evaluated, followed by quantification of plasma levels of both markers in a larger cohort of patients/subjects (∼300 cases) whose cerebrospinal fluid DJ-1 and α-synuclein levels have been determined recently. The results demonstrated that the DJ-1 and α-synuclein in blood resided predominantly in red blood cells (>95%), followed by platelets (1-4%), white blood cells and plasma (≤1%), indicating that variations in hemolysis and/or platelet contamination could have a significant effect on plasma/serum DJ-1 and α-synuclein levels. Nonetheless, after adjusting for the age, although there was a trend of decrease in DJ-1 and α-synuclein in patients with Parkinson's or Alzheimer's disease compared with healthy controls, no statistical difference was observed in this cohort between any groups, even when the extent of hemolysis and platelet contamination were controlled for. Additionally, no correlation between DJ-1 or α-synuclein and Parkinson's disease severity was identified. In conclusion, unlike in cerebrospinal fluid, total DJ-1 or α-synuclein in plasma alone is not useful as biomarkers for Parkinson's disease diagnosis or progression/severity.

Original languageEnglish (US)
Pages (from-to)78-82
Number of pages5
JournalNeuroscience Letters
Volume480
Issue number1
DOIs
StatePublished - Aug 2010

Fingerprint

Synucleins
alpha-Synuclein
Parkinson Disease
Cerebrospinal Fluid
Blood Platelets
Hemolysis
Biomarkers
Serum
Disease Progression
Alzheimer Disease
Leukocytes
Erythrocytes

Keywords

  • α-Synuclein
  • Alzheimer's disease
  • Biomarker
  • DJ-1
  • Parkinson's disease
  • Plasma

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)

Cite this

Shi, M., Zabetian, C. P., Hancock, A. M., Ginghina, C., Hong, Z., Yearout, D., ... Zhang, J. (2010). Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neuroscience Letters, 480(1), 78-82. https://doi.org/10.1016/j.neulet.2010.06.009

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. / Shi, Min; Zabetian, Cyrus P.; Hancock, Aneeka M.; Ginghina, Carmen; Hong, Zhen; Yearout, Dora; Chung, Kathryn (Kathy); Quinn, Joseph; Peskind, Elaine R.; Galasko, Douglas; Jankovic, Joseph; Leverenz, James B.; Zhang, Jing.

In: Neuroscience Letters, Vol. 480, No. 1, 08.2010, p. 78-82.

Research output: Contribution to journalArticle

Shi, M, Zabetian, CP, Hancock, AM, Ginghina, C, Hong, Z, Yearout, D, Chung, KK, Quinn, J, Peskind, ER, Galasko, D, Jankovic, J, Leverenz, JB & Zhang, J 2010, 'Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease', Neuroscience Letters, vol. 480, no. 1, pp. 78-82. https://doi.org/10.1016/j.neulet.2010.06.009
Shi, Min ; Zabetian, Cyrus P. ; Hancock, Aneeka M. ; Ginghina, Carmen ; Hong, Zhen ; Yearout, Dora ; Chung, Kathryn (Kathy) ; Quinn, Joseph ; Peskind, Elaine R. ; Galasko, Douglas ; Jankovic, Joseph ; Leverenz, James B. ; Zhang, Jing. / Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. In: Neuroscience Letters. 2010 ; Vol. 480, No. 1. pp. 78-82.
@article{7f532a7c267143c59a3ef75d523c8e4e,
title = "Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease",
abstract = "DJ-1 and α-synuclein are leading biomarkers for Parkinson's disease diagnosis and/or monitoring disease progression. A few recent investigations have determined DJ-1 and α-synuclein levels in plasma or serum, a more convenient sample source than cerebrospinal fluid; but the results were variable or even contradictory. Besides limitations in detection technology and limited number of cases in some studies, inadequate control of several important confounders likely has contributed to these inconsistent results. In this study, the relative contribution of each blood component to blood DJ-1 and α-synuclein was evaluated, followed by quantification of plasma levels of both markers in a larger cohort of patients/subjects (∼300 cases) whose cerebrospinal fluid DJ-1 and α-synuclein levels have been determined recently. The results demonstrated that the DJ-1 and α-synuclein in blood resided predominantly in red blood cells (>95{\%}), followed by platelets (1-4{\%}), white blood cells and plasma (≤1{\%}), indicating that variations in hemolysis and/or platelet contamination could have a significant effect on plasma/serum DJ-1 and α-synuclein levels. Nonetheless, after adjusting for the age, although there was a trend of decrease in DJ-1 and α-synuclein in patients with Parkinson's or Alzheimer's disease compared with healthy controls, no statistical difference was observed in this cohort between any groups, even when the extent of hemolysis and platelet contamination were controlled for. Additionally, no correlation between DJ-1 or α-synuclein and Parkinson's disease severity was identified. In conclusion, unlike in cerebrospinal fluid, total DJ-1 or α-synuclein in plasma alone is not useful as biomarkers for Parkinson's disease diagnosis or progression/severity.",
keywords = "α-Synuclein, Alzheimer's disease, Biomarker, DJ-1, Parkinson's disease, Plasma",
author = "Min Shi and Zabetian, {Cyrus P.} and Hancock, {Aneeka M.} and Carmen Ginghina and Zhen Hong and Dora Yearout and Chung, {Kathryn (Kathy)} and Joseph Quinn and Peskind, {Elaine R.} and Douglas Galasko and Joseph Jankovic and Leverenz, {James B.} and Jing Zhang",
year = "2010",
month = "8",
doi = "10.1016/j.neulet.2010.06.009",
language = "English (US)",
volume = "480",
pages = "78--82",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease

AU - Shi, Min

AU - Zabetian, Cyrus P.

AU - Hancock, Aneeka M.

AU - Ginghina, Carmen

AU - Hong, Zhen

AU - Yearout, Dora

AU - Chung, Kathryn (Kathy)

AU - Quinn, Joseph

AU - Peskind, Elaine R.

AU - Galasko, Douglas

AU - Jankovic, Joseph

AU - Leverenz, James B.

AU - Zhang, Jing

PY - 2010/8

Y1 - 2010/8

N2 - DJ-1 and α-synuclein are leading biomarkers for Parkinson's disease diagnosis and/or monitoring disease progression. A few recent investigations have determined DJ-1 and α-synuclein levels in plasma or serum, a more convenient sample source than cerebrospinal fluid; but the results were variable or even contradictory. Besides limitations in detection technology and limited number of cases in some studies, inadequate control of several important confounders likely has contributed to these inconsistent results. In this study, the relative contribution of each blood component to blood DJ-1 and α-synuclein was evaluated, followed by quantification of plasma levels of both markers in a larger cohort of patients/subjects (∼300 cases) whose cerebrospinal fluid DJ-1 and α-synuclein levels have been determined recently. The results demonstrated that the DJ-1 and α-synuclein in blood resided predominantly in red blood cells (>95%), followed by platelets (1-4%), white blood cells and plasma (≤1%), indicating that variations in hemolysis and/or platelet contamination could have a significant effect on plasma/serum DJ-1 and α-synuclein levels. Nonetheless, after adjusting for the age, although there was a trend of decrease in DJ-1 and α-synuclein in patients with Parkinson's or Alzheimer's disease compared with healthy controls, no statistical difference was observed in this cohort between any groups, even when the extent of hemolysis and platelet contamination were controlled for. Additionally, no correlation between DJ-1 or α-synuclein and Parkinson's disease severity was identified. In conclusion, unlike in cerebrospinal fluid, total DJ-1 or α-synuclein in plasma alone is not useful as biomarkers for Parkinson's disease diagnosis or progression/severity.

AB - DJ-1 and α-synuclein are leading biomarkers for Parkinson's disease diagnosis and/or monitoring disease progression. A few recent investigations have determined DJ-1 and α-synuclein levels in plasma or serum, a more convenient sample source than cerebrospinal fluid; but the results were variable or even contradictory. Besides limitations in detection technology and limited number of cases in some studies, inadequate control of several important confounders likely has contributed to these inconsistent results. In this study, the relative contribution of each blood component to blood DJ-1 and α-synuclein was evaluated, followed by quantification of plasma levels of both markers in a larger cohort of patients/subjects (∼300 cases) whose cerebrospinal fluid DJ-1 and α-synuclein levels have been determined recently. The results demonstrated that the DJ-1 and α-synuclein in blood resided predominantly in red blood cells (>95%), followed by platelets (1-4%), white blood cells and plasma (≤1%), indicating that variations in hemolysis and/or platelet contamination could have a significant effect on plasma/serum DJ-1 and α-synuclein levels. Nonetheless, after adjusting for the age, although there was a trend of decrease in DJ-1 and α-synuclein in patients with Parkinson's or Alzheimer's disease compared with healthy controls, no statistical difference was observed in this cohort between any groups, even when the extent of hemolysis and platelet contamination were controlled for. Additionally, no correlation between DJ-1 or α-synuclein and Parkinson's disease severity was identified. In conclusion, unlike in cerebrospinal fluid, total DJ-1 or α-synuclein in plasma alone is not useful as biomarkers for Parkinson's disease diagnosis or progression/severity.

KW - α-Synuclein

KW - Alzheimer's disease

KW - Biomarker

KW - DJ-1

KW - Parkinson's disease

KW - Plasma

UR - http://www.scopus.com/inward/record.url?scp=77954384099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954384099&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2010.06.009

DO - 10.1016/j.neulet.2010.06.009

M3 - Article

VL - 480

SP - 78

EP - 82

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -